September 29, 2025 · Form 4 insider transaction
Meisner Lara sold 33,807 shares of BICARA THERAPEUTICS INC at $14.75 per share, a transaction worth $498.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.